Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules

By Nabors G.S.   Braun P.A.   Herrmann D.J.   Heise M.L.   Pyle D.J.   Gravenstein S.   Schilling M.   Ferguson L.M.   Hollingshead S.K.   Briles D.E.   Becker R.S.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1743-1754

Elsevier

Access to resources Recommend Favorite

IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines

By Soininen A.   Seppala I.   Nieminen T.   Eskola J.   Kayhty H.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1889-1897

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection

By Hoan-Jong L.   Jin-Han K.   Henrichsen J.   Konradsen H.B.   Seong-Hee J.   Hee-Young S.   Hyo-Seop A.   Yong C.   Hessel L.   Sung-Woo N.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1533-1538

Elsevier

Access to resources Recommend Favorite

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials

By Cornu C.   Yzebe D.   Leophonte P.   Gaillat J.   Boissel J.P.   Cucherat M.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4780-4790

Elsevier

Access to resources Recommend Favorite

Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults

By Watson L.   Wilson B.J.   Waugh N.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2166-2173

Elsevier

Access to resources Recommend Favorite